Chinese perspectives on clinical efficacy and safety of alectinib in patients with ALK-positive advanced non-small cell lung cancer
Hui Yu,1 Si Sun,1 Xingjiang Hu,2 Jinjing Xia,3 Jialei Wang,1 Haiquan Chen41Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China; 2Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, First Affiliated Hospital...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-08-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/chinese-perspectives-on-clinical-efficacy-and-safety-of-alectinib-in-p-peer-reviewed-article-OTT |